|
Cui, Bing; Ghia, Emanuela M; Chen, Liguang et al. (2016) High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemia. Blood 128:2931-2940
|
|
Mraz, Marek; Chen, Liguang; Rassenti, Laura Z et al. (2014) miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1. Blood 124:84-95
|
|
Cui, Bing; Chen, Liguang; Zhang, Suping et al. (2014) MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia. Blood 124:546-54
|
|
Widhopf 2nd, George F; Cui, Bing; Ghia, Emanuela M et al. (2014) ROR1 can interact with TCL1 and enhance leukemogenesis in E?-TCL1 transgenic mice. Proc Natl Acad Sci U S A 111:793-8
|
|
Que, Xuchu; Widhopf 2nd, George F; Amir, Shahzada et al. (2013) IGHV1-69-encoded antibodies expressed in chronic lymphocytic leukemia react with malondialdehyde-acetaldehyde adduct, an immunodominant oxidation-specific epitope. PLoS One 8:e65203
|
|
Chuang, Han-Yu; Rassenti, Laura; Salcedo, Michelle et al. (2012) Subnetwork-based analysis of chronic lymphocytic leukemia identifies pathways that associate with disease progression. Blood 120:2639-49
|
|
Steininger, Christoph; Widhopf 2nd, George F; Ghia, Emanuela M et al. (2012) Recombinant antibodies encoded by IGHV1-69 react with pUL32, a phosphoprotein of cytomegalovirus and B-cell superantigen. Blood 119:2293-301
|
|
Choi, Michael Y; Kipps, Thomas J (2012) Inhibitors of B-cell receptor signaling for patients with B-cell malignancies. Cancer J 18:404-10
|
|
Ghia, Emanuela M; Widhopf 2nd, George F; Rassenti, Laura Z et al. (2011) Analyses of recombinant stereotypic IGHV3-21-encoded antibodies expressed in chronic lymphocytic leukemia. J Immunol 186:6338-44
|
|
Rieger, R; Whitacre, D; Cantwell, M J et al. (2009) Chimeric form of tumor necrosis factor-alpha has enhanced surface expression and antitumor activity. Cancer Gene Ther 16:53-64
|
Showing the most recent 10 out of 57 publications
